These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9507074)
21. Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX. Freedman SJ; Blostein MD; Baleja JD; Jacobs M; Furie BC; Furie B J Biol Chem; 1996 Jul; 271(27):16227-36. PubMed ID: 8663165 [TBL] [Abstract][Full Text] [Related]
22. Membrane binding properties of the factor IX gamma-carboxyglutamic acid-rich domain prepared by chemical synthesis. Jacobs M; Freedman SJ; Furie BC; Furie B J Biol Chem; 1994 Oct; 269(41):25494-501. PubMed ID: 7929250 [TBL] [Abstract][Full Text] [Related]
23. Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia B. Christophe OD; Lenting PJ; Cherel G; Boon-Spijker M; Lavergne JM; Boertjes R; Briquel ME; de Goede-Bolder A; Goudemand J; Gaillard S; d'Oiron R; Meyer D; Mertens K Blood; 2001 Sep; 98(5):1416-23. PubMed ID: 11520790 [TBL] [Abstract][Full Text] [Related]
24. Tethered processivity of the vitamin K-dependent carboxylase: factor IX is efficiently modified in a mechanism which distinguishes Gla's from Glu's and which accounts for comprehensive carboxylation in vivo. Stenina O; Pudota BN; McNally BA; Hommema EL; Berkner KL Biochemistry; 2001 Aug; 40(34):10301-9. PubMed ID: 11513608 [TBL] [Abstract][Full Text] [Related]
25. Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain. Bajaj SP; Sabharwal AK; Gorka J; Birktoft JJ Proc Natl Acad Sci U S A; 1992 Jan; 89(1):152-6. PubMed ID: 1729682 [TBL] [Abstract][Full Text] [Related]
26. Structure of the calcium ion-bound gamma-carboxyglutamic acid-rich domain of factor IX. Freedman SJ; Furie BC; Furie B; Baleja JD Biochemistry; 1995 Sep; 34(38):12126-37. PubMed ID: 7547952 [TBL] [Abstract][Full Text] [Related]
27. The entire gamma-carboxyglutamic acid- and helical stack-domains of human coagulation factor IX are required for optimal binding to its endothelial cell receptor. Prorok M; Geng JP; Warder SE; Castellino FJ Int J Pept Protein Res; 1996 Sep; 48(3):281-5. PubMed ID: 8897096 [TBL] [Abstract][Full Text] [Related]
28. An anti-EGF monoclonal antibody that detects intramolecular communication in factor IX. Persson KE; Knobe KE; Stenflo J Biochem Biophys Res Commun; 2001 Sep; 286(5):1039-44. PubMed ID: 11527405 [TBL] [Abstract][Full Text] [Related]
29. Accumulation of the recombinant factor VIIa in rat bone: importance of the Gla-domain and relevance to factor IX, another vitamin K-dependent clotting factor. Thomsen MK; Wildgoose P; Nilsson P; Hedner U Pharmacol Toxicol; 1993 Sep; 73(3):127-32. PubMed ID: 7903449 [TBL] [Abstract][Full Text] [Related]
30. Crystal structure of Mg2+- and Ca2+-bound Gla domain of factor IX complexed with binding protein. Shikamoto Y; Morita T; Fujimoto Z; Mizuno H J Biol Chem; 2003 Jun; 278(26):24090-4. PubMed ID: 12695512 [TBL] [Abstract][Full Text] [Related]
31. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII. Geng JP; Castellino FJ Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404 [TBL] [Abstract][Full Text] [Related]
32. Transfer of specific endothelial cell-binding properties from the procoagulant protein human factor IX into the anticoagulant protein human protein C. Geng JP; Christiansen WT; Plow EF; Castellino FJ Biochemistry; 1995 Jul; 34(26):8449-57. PubMed ID: 7541242 [TBL] [Abstract][Full Text] [Related]
33. Identification and purification of vitamin K-dependent proteins and peptides with monoclonal antibodies specific for gamma -carboxyglutamyl (Gla) residues. Brown MA; Stenberg LM; Persson U; Stenflo J J Biol Chem; 2000 Jun; 275(26):19795-802. PubMed ID: 10779512 [TBL] [Abstract][Full Text] [Related]
34. The propeptides of human protein C, factor VII, and factor IX are exchangeable with regard to directing gamma-carboxylation of these proteins. Geng JP; Castellino FJ Thromb Haemost; 1996 Aug; 76(2):205-7. PubMed ID: 8865532 [TBL] [Abstract][Full Text] [Related]
35. The factor IX gamma-carboxyglutamic acid (Gla) domain is involved in interactions between factor IX and factor XIa. Aktimur A; Gabriel MA; Gailani D; Toomey JR J Biol Chem; 2003 Mar; 278(10):7981-7. PubMed ID: 12496253 [TBL] [Abstract][Full Text] [Related]
36. Conformational changes in an epitope localized to the NH2-terminal region of protein C. Evidence for interaction of protein C domains. Orthner CL; Madurawe RD; Velander WH; Drohan WN; Battey FD; Strickland DK J Biol Chem; 1989 Nov; 264(31):18781-8. PubMed ID: 2478552 [TBL] [Abstract][Full Text] [Related]
37. Lysine 5 and phenylalanine 9 of the factor IX omega-loop interact with phosphatidylserine in a membrane-mimetic environment. Grant MA; Baikeev RF; Gilbert GE; Rigby AC Biochemistry; 2004 Dec; 43(49):15367-78. PubMed ID: 15581349 [TBL] [Abstract][Full Text] [Related]
38. Location of the platelet binding site in zymogen coagulation factor IX. Melton LG; Li T; Stafford DW; Gabriel DA Blood Coagul Fibrinolysis; 2001 Jun; 12(4):237-43. PubMed ID: 11460006 [TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody (VII-M31) to bovine factor VII: a specific epitope in the gamma-carboxyglutamic acid domain. Higashi S; Kawabata S; Nishimura H; Funasaki H; Ohyama S; Miyamoto S; Funatsu A; Iwanaga S J Biochem; 1990 Oct; 108(4):654-62. PubMed ID: 1705545 [TBL] [Abstract][Full Text] [Related]